Mark T. Taylor
Fondateur chez Hallux, Inc.
Profil
Mark T.
Taylor is the founder of Hallux, Inc. founded in 2012, where he currently holds the position of President, Chief Executive Officer & Director.
He previously worked as a Director at Embic Corp., an Executive VP-North American Pharmaceuticals at Bausch Health Americas, Inc. from 1999 to 2002, an Institutional Salesman at Lehman Brothers, Inc., a Vice President-Business Development at Actavis, Inc. from 1995 to 1998, an SVP-Corporate Development & Investor Relations at Obagi Medical Products, Inc. from 2012 to 2013, an Institutional Sales Professional at ROTH Capital Partners LLC in 2012, and a Senior Research Analyst at ROTH Capital Partners LLC.
He started his career as an Institutional Salesman at Alex.
Brown & Sons, Inc. from 1986 to 1994.
Mr. Taylor received his undergraduate degree from Tulane University (Louisiana) in 1980.
Postes actifs de Mark T. Taylor
| Sociétés | Poste | Début |
|---|---|---|
Hallux, Inc.
 Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Fondateur | 01/01/2012 |
Anciens postes connus de Mark T. Taylor
| Sociétés | Poste | Fin |
|---|---|---|
Obagi Medical Products, Inc.
 Obagi Medical Products, Inc. Pharmaceuticals: MajorHealth Technology Obagi Medical Products, Inc. develops, markets, and sells proprietary topical aesthetic and therapeutic prescription-strength skin care systems. It designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage and are primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. The company was founded in 1988 and is headquartered in Irvine, CA. | Investor Relations Contact | 03/01/2013 |
ROTH Capital Partners LLC
 ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Ventes Institutionnelles | 01/08/2012 |
ROTH Capital Partners LLC
ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Analyst-Equity | 31/10/2007 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2002 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 31/12/1998 |
Formation de Mark T. Taylor
| Tulane University (Louisiana) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
ROTH Capital Partners LLC
ROTH Capital Partners LLC Investment Banks/BrokersFinance ROTH Capital Partners LLC is a broker/dealer headquartered in Newport Beach, California. The firm was founded in 2001 and is a subsidiary of CR Financial Holdings, Inc. They offer institutional sales and trading services. Their broad institutional coverage includes investors in North America, Canada, UK, Europe and other international territories. | Finance |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
| Alex. Brown & Sons, Inc. | Finance |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Obagi Medical Products, Inc.
Obagi Medical Products, Inc. Pharmaceuticals: MajorHealth Technology Obagi Medical Products, Inc. develops, markets, and sells proprietary topical aesthetic and therapeutic prescription-strength skin care systems. It designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage and are primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. The company was founded in 1988 and is headquartered in Irvine, CA. | Health Technology |
Embic Corp.
 Embic Corp. Information Technology ServicesTechnology Services Medical Care Corp. specializes in developing technologies for the precise measurement and monitoring of cognitive performance. The company was founded by William R. Shankle and Junko Hara in 1999 and is headquartered in Newport Beach, CA. | Technology Services |
Hallux, Inc.
Hallux, Inc. Pharmaceuticals: MajorHealth Technology Hallux, Inc. provides pharmaceutical services. It develops a new terbinafine dosage form and subungual route of administration for the treatment of onychomycosis. The company was founded by Mark T. Taylor, Jay Edward Birnbaum, Hendrik Arend Kroon and Robert Orr in 2012 and is headquartered in Laguna Hills, CA. | Health Technology |